publication venue for
- Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study. 45:623-638. 2022
- Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies. 44:467-478. 2021
- Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis. 41:277-284. 2018
- Erratum to: Adverse Gastrointestinal Events with Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Nested Case–Control Study. 37:989-989. 2014
- Adverse Gastrointestinal Events with Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Nested Case–Control Study. 37:723-733. 2014
- A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery. 34:449-463. 2011
- Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease. 29:1133-1152. 2006
- Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis. 28:721-730. 2005
- Long-Term Tolerability of the Bisphosphonates in Postmenopausal Osteoporosis. 25:781-790. 2002
- Corticosteroid-Induced Osteoporosis. 24:607-624. 2001
- Comparative Tolerability of the Newer Fluoroquinolone Antibacterials. 21:407-421. 1999
- Heparin-Induced Thrombocytopenia. 17:325-341. 1997
- The ??2-Agonist Controversy. 11:259-283. 1994
- Risk-Benefit Assessment of Antiarrhythmic Drugs. 6:323-331. 1991